{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T08:01:32Z","timestamp":1774425692054,"version":"3.50.1"},"reference-count":44,"publisher":"Impact Journals, LLC","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,3,6]]},"DOI":"10.18632\/oncotarget.24523","type":"journal-article","created":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T09:42:24Z","timestamp":1518860544000},"page":"14597-14607","source":"Crossref","is-referenced-by-count":11,"title":["Calpastatin phosphorylation regulates radiation-induced calpain activity in glioblastoma"],"prefix":"10.18632","volume":"9","author":[{"given":"Emily A.","family":"Bassett","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamalakannan","family":"Palanichamy","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell","family":"Pearson","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph P.","family":"McElroy","sequence":"additional","affiliation":[{"name":"Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saikh Jaharul","family":"Haque","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica Hlavin","family":"Bell","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnab","family":"Chakravarti","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2018,2,19]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1001\/jama.2013.280319","article-title":"Glioblastoma and other malignant gliomas: a clinical review","volume":"310","author":"DeAngelis","year":"2013","journal-title":"JAMA"},{"key":"2","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Ludwin","year":"2005","journal-title":"N Engl J Med"},{"key":"3","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/WCO.0b013e3283327d33","article-title":"Combining drugs and radiotherapy: from the bench to the bedside","volume":"22","author":"Chakravarti","year":"2009","journal-title":"Curr Opin Neurol"},{"key":"4","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/ng.3590","article-title":"Clonal evolution of glioblastoma under therapy","volume":"48","author":"Park","year":"2016","journal-title":"Nat Genet"},{"key":"5","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature05236","article-title":"Glioma stem cells promote radioresistance by preferential activation of the DNA damage response","volume":"444","author":"Rich","year":"2006","journal-title":"Nature"},{"key":"6","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/emboj.2011.10","article-title":"L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1","volume":"30","author":"Bao","year":"2011","journal-title":"EMBO J"},{"key":"7","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1158\/1078-0432.CCR-08-2079","article-title":"andradiosensitization of glioblastoma cells by the poly (ADP-ribose) polymerase inhibitor E7016","volume":"15","author":"Camphausen","year":"2009","journal-title":"Clin Cancer Res"},{"key":"8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1748-717X-4-43","article-title":"Radiation-induced Akt activation modulates radioresistance in human glioblastoma cells","volume":"4","author":"Waldman","year":"2009","journal-title":"Radiat Oncol"},{"key":"9","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/ijc.24402","article-title":"The induction of autophagy by gamma-radiation contributes to the radioresistance of glioma stem cells","volume":"125","author":"Brodie","year":"2009","journal-title":"Int J Cancer"},{"key":"10","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nrc3050","article-title":"The calpain system and cancer","volume":"11","author":"Martin","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1517\/14728222.2011.553611","article-title":"Calpains as potential anti-cancer targets","volume":"15","author":"Wells","year":"2011","journal-title":"Expert Opin Ther Targets"},{"key":"12","doi-asserted-by":"crossref","first-page":"9022","DOI":"10.1074\/jbc.C100700200","article-title":"Calpastatin subdomains A and C are activators of calpain","volume":"277","author":"Friedrich","year":"2002","journal-title":"J Biol Chem"},{"issue":"Pt 2","key":"13","first-page":"467","article-title":"Changes in intracellular localization of calpastatin during calpain activation","volume":"343","author":"Pontremoli","year":"1999","journal-title":"Biochem J"},{"key":"14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1042\/bj3540025","article-title":"Changes in intracellular calpastatin localization are mediated by reversible phosphorylation","volume":"354","author":"Melloni","year":"2001","journal-title":"Biochem J"},{"key":"15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.abb.2014.09.018","article-title":"Calpains and cancer: friends or enemies?","volume":"564","author":"Maellaro","year":"2014","journal-title":"Arch Biochem Biophys"},{"key":"16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/cns.12248","article-title":"Increased expression of Capn4 is associated with the malignancy of human glioma","volume":"20","author":"Mao","year":"2014","journal-title":"CNS Neurosci Ther"},{"key":"17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/(SICI)1097-0215(19990219)84:1<6::AID-IJC2>3.0.CO;2-T","article-title":"Expression of calpain I messenger RNA in human renal cell carcinoma: correlation with lymph node metastasis and histological type","volume":"84","author":"Welter","year":"1999","journal-title":"Int J Cancer"},{"key":"18","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1158\/1055-9965.1604.13.10","article-title":"Overexpression of m-calpain in human colorectal adenocarcinomas","volume":"13","author":"Sharma","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"19","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/cbin.10062","article-title":"Calpains are required for invasive and metastatic potentials of human HCC cells","volume":"37","author":"Jiang","year":"2013","journal-title":"Cell Biol Int"},{"key":"20","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1038\/bcj.2011.50","article-title":"Elevated calpain activity in acute myelogenous leukemia correlates with decreased calpastatin expression","volume":"2","author":"Berger","year":"2012","journal-title":"Blood Cancer J"},{"key":"21","doi-asserted-by":"crossref","first-page":"10700","DOI":"10.1158\/0008-5472.CAN-05-1666","article-title":"Cyclin E both regulates and is regulated by calpain 2, a protease associated with metastatic breast cancer phenotype","volume":"65","author":"Mudryj","year":"2005","journal-title":"Cancer Res"},{"key":"22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1476-4598-3-36","article-title":"Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax: Bcl-2 ratio and preventing proteolytic activities","volume":"3","author":"Ray","year":"2004","journal-title":"Mol Cancer"},{"key":"23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF02966957","article-title":"Ca&sup2+;-Dependent Neutral Protease (Calpain) Activity in Breast Cancer Tissue and Estrogen Receptor Status","volume":"3","author":"Takai","year":"1996","journal-title":"Breast Cancer"},{"key":"24","first-page":"5085","article-title":"Investigation of peroxiredoxin IV as a calpain-regulated pathway in cancer","volume":"30","author":"Cottin","year":"2010","journal-title":"Anticancer Res"},{"key":"25","first-page":"2837","article-title":"Immunhistochemical analysis for expression of calpain 1, calpain 2 and calpastatin in endometrial cancer","volume":"30","author":"Friedrich","year":"2010","journal-title":"Anticancer Res"},{"key":"26","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1101\/gad.1200304","article-title":"Phosphorylation of SMC1 is a critical downstream event in the ATM-NBS1-BRCA1 pathway","volume":"18","author":"Kastan","year":"2004","journal-title":"Genes Dev"},{"key":"27","doi-asserted-by":"crossref","first-page":"19855","DOI":"10.1073\/pnas.0707579104","article-title":"Profiling of UV-induced ATM\/ATR signaling pathways","volume":"104","author":"Comb","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"28","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.dnarep.2007.04.011","article-title":"Characterisation of the sites of DNA damage-induced 53BP1 phosphorylation catalysed by ATM and ATR","volume":"6","author":"Rouse","year":"2007","journal-title":"DNA Repair (Amst)"},{"key":"29","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/gb-2011-12-8-r78","article-title":"A phospho-proteomic screen identifies substrates of the checkpoint kinase Chk1","volume":"12","author":"Jackson","year":"2011","journal-title":"Genome Biol"},{"key":"30","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/sj.cdd.4400425","article-title":"Calpain activation is upstream of caspases in radiation-induced apoptosis","volume":"5","author":"Watters","year":"1998","journal-title":"Cell Death Differ"},{"key":"31","doi-asserted-by":"crossref","first-page":"W226","DOI":"10.1093\/nar\/gki471","article-title":"KinasePhos: a web tool for identifying protein kinase-specific phosphorylation sites","volume":"33","author":"Horng","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"32","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1002\/pmic.200300771","article-title":"Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence","volume":"4","author":"Brunak","year":"2004","journal-title":"Proteomics"},{"key":"33","first-page":"1000094","article-title":"Casein Kinase 2: a novel player in glioblastoma therapy and cancer stem cells","volume":"8","author":"Li","year":"2013","journal-title":"J Mol Genet Med"},{"key":"34","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1200\/JCO.2004.07.193","article-title":"The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas","volume":"22","author":"Loeffler","year":"2004","journal-title":"J Clin Oncol"},{"key":"35","first-page":"200","article-title":"Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling","volume":"62","author":"Dyson","year":"2002","journal-title":"Cancer Res"},{"key":"36","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nsb0402-239","article-title":"How calpain is activated by calcium","volume":"9","author":"Ikura","year":"2002","journal-title":"Nat Struct Biol"},{"key":"37","doi-asserted-by":"crossref","first-page":"21371","DOI":"10.1074\/jbc.M801462200","article-title":"Regulation of calpain activity by c-Myc through calpastatin and promotion of transformation in c-Myc-negative cells by calpastatin suppression","volume":"283","author":"Berger","year":"2008","journal-title":"J Biol Chem"},{"key":"38","doi-asserted-by":"crossref","first-page":"e271","DOI":"10.1038\/cddis.2012.10","article-title":"Inhibition of Casein kinase-2 induces p53-dependent cell cycle arrest and sensitizes glioblastoma cells to tumor necrosis factor (TNFalpha)-induced apoptosis through SIRT1 inhibition","volume":"3","author":"Sen","year":"2012","journal-title":"Cell Death Dis"},{"key":"39","doi-asserted-by":"crossref","first-page":"6484","DOI":"10.1158\/1078-0432.CCR-13-0265","article-title":"Targeting protein kinase CK2 suppresses prosurvival signaling pathways and growth of glioblastoma","volume":"19","author":"Benveniste","year":"2013","journal-title":"Clin Cancer Res"},{"key":"40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.canlet.2013.11.008","article-title":"Protein kinase CK2 is required for the recruitment of 53BP1 to sites of DNA double-strand break induced by radiomimetic drugs","volume":"345","author":"Issinger","year":"2014","journal-title":"Cancer Lett"},{"key":"41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2199-13-7","article-title":"Protein kinase CK2 localizes to sites of DNA double-strand break regulating the cellular response to DNA damage","volume":"13","author":"Guerra","year":"2012","journal-title":"BMC Mol Biol"},{"key":"42","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/cas.13024","article-title":"Calpain inhibitor calpeptin suppresses pancreatic cancer by disrupting cancer-stromal interactions in a mouse xenograft model","volume":"107","author":"Nakamura","year":"2016","journal-title":"Cancer Sci"},{"key":"43","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2174\/138161206775474314","article-title":"Calpain inhibition: a therapeutic strategy targeting multiple disease states","volume":"12","author":"Carragher","year":"2006","journal-title":"Curr Pharm Des"},{"key":"44","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1021\/pr1002214","article-title":"Brain phosphoproteome obtained by a FASP-based method reveals plasma membrane protein topology","volume":"9","author":"Mann","year":"2010","journal-title":"J Proteome Res"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.24523","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T13:35:45Z","timestamp":1660484145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.24523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,19]]},"references-count":44,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2018,3,6]]}},"alternative-id":["24523","29581866"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.24523","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,19]]}}}